文献速递免疫规划妇幼与学校卫生

儿童接种黄热病疫苗后体液免疫的持续时间

Duration of post-vaccination humoral immunity against yellow fever in children.
PubMed 文献 · Vaccine · 2019-10-04

这项横断面研究纳入巴西东南部大都市区824名9月龄至12岁、有接种记录的儿童,用蚀斑减少中和试验检测黄热病中和抗体。接种后时间越长,血清阳性率与几何平均滴度下降越明显。作者认为数据支持在黄热病毒在人或其它灵长类中循环地区儿童需再接种,并支持将基础免疫于两岁内完成者的加强剂次改为4岁。

要点

  • 接种后1-6个月血清阳性率为86.7%,几何平均滴度为47.9。
  • 接种后73-100个月血清阳性率降至42.2%,几何平均滴度降至8.6。
  • 作者认为数据支持黄热病毒循环地区儿童需再接种,并支持加强剂次改为4岁。

核心结论

  • 与既往成人研究结果类似,这些数据支持生活在黄热病毒于人或其它灵长类中循环地区的儿童需再接种。
  • 数据还支持将基础免疫于出生后前两年内完成者的加强剂次改为4岁。

研究设计与样本

  • 横断面研究,纳入巴西东南部大都市区初级保健单位招募的9月龄至12岁、接种记录可获取的儿童。
  • 共检测824名于2010年8月至2011年7月招募的儿童。
  • 采用蚀斑减少中和试验评估黄热病中和抗体血清学状态(阴性、不确定、阳性)及几何平均滴度(倒数稀释度)。
  • 按接种后时间分类比较,并以接种后1-6个月为参照计算血清阳性的比值比(OR)。

主要发现

  • 接种后1-6个月血清阳性率为86.7%(95%CI 80.5-91.4),几何平均滴度为47.9(95%CI 38.3-59.9)。
  • 接种后31-72个月血清阳性率为59.0%(95%CI 49.7-67.8),几何平均滴度为14.8(95%CI 11.6-19.1)。
  • 接种后73-100个月血清阳性率为42.2%(95%CI 33.8-51.0),几何平均滴度为8.6(95%CI 7.1-12.1)。

临床怎么用

  • 作者认为数据支持黄热病毒在人或其它灵长类中循环地区的儿童需再接种。
  • 作者认为数据支持将基础免疫于出生后前两年内完成者的加强剂次改为4岁。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Vaccination is the most important measure for prevention and control of yellow fever. It is recommended by the World Health Organization (WHO) for residents of endemic areas and travelers to risk areas. In 2013, the WHO discontinued the recommendation of booster doses every 10 years, indicating a single dose as sufficient for lifelong protection. OBJECTIVE: Considering the lower immune response to YF vaccine in children compared to adults, this study was set out to assess the duration of immunity to YF in children vaccinated in the first two years of life. METHODS: This cross-sectional study involved children aged 9 months to 12 years with accessible vaccination records recruited in primary care units from a metropolitan area in Southeast Brazil. The serologic status (negative, indeterminate and positive), and geometric mean titers (GMT, inverse dilution) of neutralizing antibodies against YF obtained by Plaque Reduction Neutralization Test was assessed across categories of time after YF vaccination. The strength of association of seropositivity with time was assessed by the odds ratio (OR) taking recent vaccination (1-6 months) as reference. RESULTS: A total of 824 children recruited from August 2010 to July 2011were tested. The proportion of seropositivity (95% C.I.) and GMT (95% C.I.) dropped markedly across time periods: from 86.7% (80.5-91.4%), GMT 47.9 (38.3-59.9) in newly vaccinated to 59.0% (49.7-67.8%), GMT 14.8 (11.6-19.1) and 42.2% (33.8-51.0), GMT 8.6 (7.1-12.1), respectively in the subgroups vaccinated 31-72 months and 73-100 months before. CONCLUSIONS: Analogous to previous findings in adults, these data support the need for revaccination of children living in areas with yellow fever virus circulation in humans or in other primates. The data also supported the change of a booster dose to 4 years of age for those primarily vaccinated for yellow fever in the first two years of life.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. de Noronha TG, de Lourdes de Sousa Maia M, Geraldo Leite Ribeiro J, et al. Duration of post-vaccination humoral immunity against yellow fever in children. Vaccine. 2019. PMID: 31590934. doi:10.1016/j.vaccine.2019.09.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。